Table 2.
Zero-order correlations among study variables (N = 144).
| 1. | 2. | 3. | 4. | 5. | 6. | 7. | 8. | 9. | 10. | 11. | 12. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Opioids | -- | |||||||||||
| 2. | Female | −0.10 | -- | ||||||||||
| 3. | AHI | 0.20* | −0.13 | -- | |||||||||
| 4. | BDI–II | 0.17* | 0.04 | −0.13 | -- | ||||||||
| 5. | Sleep meds | 0.14 | −0.02 | 0.15 | 0.12 | -- | |||||||
| 6. | Non–opioids | −0.10 | 0.12 | −0.03 | −0.08 | 0.01 | -- | ||||||
| 7. | Pain | 0.22** | −0.17* | −0.02 | 0.39*** | −0.08 | −0.24** | -- | |||||
| 8. | SOL self–report | 0.19* | −0.04 | 0.14 | 0.24** | 0.24** | −0.02 | 0.01 | -- | ||||
| 9. | SOL actigraphy | 0.25** | −0.15 | 0.04 | 0.29** | 0.10 | −0.16 | 0.24** | 0.48*** | -- | |||
| 10. | WASO self–report | 0.03 | 0.11 | −0.09 | 0.23 | −0.12 | −0.11 | 0.22** | 0.08 | −0.01 | -- | ||
| 11. | WASO actigraphy | 0.21* | 0.07 | 0.13 | 0.06 | 0.07 | −0.01 | 0.11 | 0.19* | 0.24** | 0.28** | -- | |
| 12. | Quality | −0.14 | 0.02 | 0.09 | −0.14 | 0.17* | 0.23 | −0.38*** | −0.06 | −0.06 | −0.30*** | −0.05 | -- |
| 13. | Time in bed | 0.22** | −0.02 | 0.08 | 0.24** | 0.31*** | −0.05 | −0.03 | 0.42*** | 0.36*** | 0.11 | 0.50*** | 0.10 |
Note. p < .05.
p < .01.
p < .001.
AHI = apnea hypopnea index. BDI-II = Beck Depression Inventory. Sleep meds = yes/no use of sleep medication. Non-opioids = yes/no use of non-opioid medication. Opioids = yes/no use of opioid medication. Pain = average pain intensity (visual analogue scale). Quality = sleep quality. SOL = sleep onset latency. TIB = time in bed. WASO = wake after sleep onset.